Pheon Therapeutics is a preclinical-stage oncology biotechnology company developing next-generation antibody-drug conjugates (ADCs) for a wide range of hard-to-treat solid tumors. Leveraging two decades of ADC experience, Pheon arms monoclonal antibodies against both novel and clinically validated targets with warheads from its proprietary payload… - View it on GitHub